Reviews Mannitol Injection


No reviews yet.

Mannitol IV Drug Description
Mannitol
(mannitol) Injection, Solution
Flexible Plastic Container
Fliptop Vial
DRUG DESCRIPTION
Mannitol I.V. (Mannitol Injection, USP) is a sterile, nonpyrogenic solution
of mannitol in water for injection available in concentrations of 5%, 10%, 15%,
20% in flexible plastic containers and 25% in a Fliptop vial for administration
by intravenous infusion only.
The content and characteristics of the available concentrations are as follows:





Conc. (%)
g/100 mL
mOsmol/liter (calc.)
pH*


5
5
274
6.3 (4.5 to 7.0)


10
10
549
6.3 (4.5 to 7.0)


15
15
823
6.3 (4.5 to 7.0)


20
20
1098
6.3 (4.5 to 7.0)


25
25
1372
5.9 (4.5 to 7.0)


*Concentrations up to 20% may contain sodium bicarbonate for pH adjustment; the 25% concentration may contain sodium
bicarbonate and/or hydrochloric acid for pH adjustment.



The solutions contain no bacteriostat, antimicrobial agent or added buffer
(except for pH adjustment) and each is intended only as a single-dose injection.
When smaller doses are required the unused portion should be discarded.
Mannitol Injection, USP is a parenteral obligatory osmotic diuretic.
Mannitol, USP is chemically designated D-mannitol (C6H14O6),
a white crystalline powder or free-flowing granules freely soluble in water.
It has the following structural formula:








Water for Injection, USP is chemically designated H20.
The flexible plastic container is fabricated from a specially formulated polyvinylchloride.
Water can permeate from inside the container into the overwrap, but not in amounts
sufficient to affect the solution significantly. Solutions in contact with the
plastic container may leach out certain chemical components from the plastic
in very small amounts; however, biological testing was supportive of the safety
of the plastic container materials. Exposure to temperatures above 25°C/77°F
during transport and storage will lead to minor losses in moisture content.
Higher temperatures lead to greater losses. It is unlikely that these minor
losses will lead to clinically significant changes within the expiration period.
Last reviewed on RxList: 9/30/2008




Mannitol IV Drug Description
Mannitol
(mannitol) Injection, Solution
Flexible Plastic Container
Fliptop Vial
DRUG DESCRIPTION
Mannitol I.V. (Mannitol Injection, USP) is a sterile, nonpyrogenic solution
of mannitol in water for injection available in concentrations of 5%, 10%, 15%,
20% in flexible plastic containers and 25% in a Fliptop vial for administration
by intravenous infusion only.
The content and characteristics of the available concentrations are as follows:





Conc. (%)
g/100 mL
mOsmol/liter (calc.)
pH*


5
5
274
6.3 (4.5 to 7.0)


10
10
549
6.3 (4.5 to 7.0)


15
15
823
6.3 (4.5 to 7.0)


20
20
1098
6.3 (4.5 to 7.0)


25
25
1372
5.9 (4.5 to 7.0)


*Concentrations up to 20% may contain sodium bicarbonate for pH adjustment; the 25% concentration may contain sodium
bicarbonate and/or hydrochloric acid for pH adjustment.



The solutions contain no bacteriostat, antimicrobial agent or added buffer
(except for pH adjustment) and each is intended only as a single-dose injection.
When smaller doses are required the unused portion should be discarded.
Mannitol Injection, USP is a parenteral obligatory osmotic diuretic.
Mannitol, USP is chemically designated D-mannitol (C6H14O6),
a white crystalline powder or free-flowing granules freely soluble in water.
It has the following structural formula:








Water for Injection, USP is chemically designated H20.
The flexible plastic container is fabricated from a specially formulated polyvinylchloride.
Water can permeate from inside the container into the overwrap, but not in amounts
sufficient to affect the solution significantly. Solutions in contact with the
plastic container may leach out certain chemical components from the plastic
in very small amounts; however, biological testing was supportive of the safety
of the plastic container materials. Exposure to temperatures above 25°C/77°F
during transport and storage will lead to minor losses in moisture content.
Higher temperatures lead to greater losses. It is unlikely that these minor
losses will lead to clinically significant changes within the expiration period.
Last reviewed on RxList: 9/30/2008




Mannitol IV Drug Description
Mannitol
(mannitol) Injection, Solution
Flexible Plastic Container
Fliptop Vial
DRUG DESCRIPTION
Mannitol I.V. (Mannitol Injection, USP) is a sterile, nonpyrogenic solution
of mannitol in water for injection available in concentrations of 5%, 10%, 15%,
20% in flexible plastic containers and 25% in a Fliptop vial for administration
by intravenous infusion only.
The content and characteristics of the available concentrations are as follows:





Conc. (%)
g/100 mL
mOsmol/liter (calc.)
pH*


5
5
274
6.3 (4.5 to 7.0)


10
10
549
6.3 (4.5 to 7.0)


15
15
823
6.3 (4.5 to 7.0)


20
20
1098
6.3 (4.5 to 7.0)


25
25
1372
5.9 (4.5 to 7.0)


*Concentrations up to 20% may contain sodium bicarbonate for pH adjustment; the 25% concentration may contain sodium
bicarbonate and/or hydrochloric acid for pH adjustment.



The solutions contain no bacteriostat, antimicrobial agent or added buffer
(except for pH adjustment) and each is intended only as a single-dose injection.
When smaller doses are required the unused portion should be discarded.
Mannitol Injection, USP is a parenteral obligatory osmotic diuretic.
Mannitol, USP is chemically designated D-mannitol (C6H14O6),
a white crystalline powder or free-flowing granules freely soluble in water.
It has the following structural formula:








Water for Injection, USP is chemically designated H20.
The flexible plastic container is fabricated from a specially formulated polyvinylchloride.
Water can permeate from inside the container into the overwrap, but not in amounts
sufficient to affect the solution significantly. Solutions in contact with the
plastic container may leach out certain chemical components from the plastic
in very small amounts; however, biological testing was supportive of the safety
of the plastic container materials. Exposure to temperatures above 25°C/77°F
during transport and storage will lead to minor losses in moisture content.
Higher temperatures lead to greater losses. It is unlikely that these minor
losses will lead to clinically significant changes within the expiration period.
Last reviewed on RxList: 9/30/2008




Mannitol IV Drug Description
Mannitol
(mannitol) Injection, Solution
Flexible Plastic Container
Fliptop Vial
DRUG DESCRIPTION
Mannitol I.V. (Mannitol Injection, USP) is a sterile, nonpyrogenic solution
of mannitol in water for injection available in concentrations of 5%, 10%, 15%,
20% in flexible plastic containers and 25% in a Fliptop vial for administration
by intravenous infusion only.
The content and characteristics of the available concentrations are as follows:





Conc. (%)
g/100 mL
mOsmol/liter (calc.)
pH*


5
5
274
6.3 (4.5 to 7.0)


10
10
549
6.3 (4.5 to 7.0)


15
15
823
6.3 (4.5 to 7.0)


20
20
1098
6.3 (4.5 to 7.0)


25
25
1372
5.9 (4.5 to 7.0)


*Concentrations up to 20% may contain sodium bicarbonate for pH adjustment; the 25% concentration may contain sodium
bicarbonate and/or hydrochloric acid for pH adjustment.



The solutions contain no bacteriostat, antimicrobial agent or added buffer
(except for pH adjustment) and each is intended only as a single-dose injection.
When smaller doses are required the unused portion should be discarded.
Mannitol Injection, USP is a parenteral obligatory osmotic diuretic.
Mannitol, USP is chemically designated D-mannitol (C6H14O6),
a white crystalline powder or free-flowing granules freely soluble in water.
It has the following structural formula:








Water for Injection, USP is chemically designated H20.
The flexible plastic container is fabricated from a specially formulated polyvinylchloride.
Water can permeate from inside the container into the overwrap, but not in amounts
sufficient to affect the solution significantly. Solutions in contact with the
plastic container may leach out certain chemical components from the plastic
in very small amounts; however, biological testing was supportive of the safety
of the plastic container materials. Exposure to temperatures above 25°C/77°F
during transport and storage will lead to minor losses in moisture content.
Higher temperatures lead to greater losses. It is unlikely that these minor
losses will lead to clinically significant changes within the expiration period.
Last reviewed on RxList: 9/30/2008




Mannitol IV Drug Description
Mannitol
(mannitol) Injection, Solution
Flexible Plastic Container
Fliptop Vial
DRUG DESCRIPTION
Mannitol I.V. (Mannitol Injection, USP) is a sterile, nonpyrogenic solution
of mannitol in water for injection available in concentrations of 5%, 10%, 15%,
20% in flexible plastic containers and 25% in a Fliptop vial for administration
by intravenous infusion only.
The content and characteristics of the available concentrations are as follows:





Conc. (%)
g/100 mL
mOsmol/liter (calc.)
pH*


5
5
274
6.3 (4.5 to 7.0)


10
10
549
6.3 (4.5 to 7.0)


15
15
823
6.3 (4.5 to 7.0)


20
20
1098
6.3 (4.5 to 7.0)


25
25
1372
5.9 (4.5 to 7.0)


*Concentrations up to 20% may contain sodium bicarbonate for pH adjustment; the 25% concentration may contain sodium
bicarbonate and/or hydrochloric acid for pH adjustment.



The solutions contain no bacteriostat, antimicrobial agent or added buffer
(except for pH adjustment) and each is intended only as a single-dose injection.
When smaller doses are required the unused portion should be discarded.
Mannitol Injection, USP is a parenteral obligatory osmotic diuretic.
Mannitol, USP is chemically designated D-mannitol (C6H14O6),
a white crystalline powder or free-flowing granules freely soluble in water.
It has the following structural formula:








Water for Injection, USP is chemically designated H20.
The flexible plastic container is fabricated from a specially formulated polyvinylchloride.
Water can permeate from inside the container into the overwrap, but not in amounts
sufficient to affect the solution significantly. Solutions in contact with the
plastic container may leach out certain chemical components from the plastic
in very small amounts; however, biological testing was supportive of the safety
of the plastic container materials. Exposure to temperatures above 25°C/77°F
during transport and storage will lead to minor losses in moisture content.
Higher temperatures lead to greater losses. It is unlikely that these minor
losses will lead to clinically significant changes within the expiration period.
Last reviewed on RxList: 9/30/2008





Other reviews about Mannitol Injection on wordpress

MS Therapies - Betaseron
  by Thixia
Brand Name Betaseron   Common Name interferon beta-1b   How does this medication work? What will it do for me?   Interferon beta-1b belongs to a class of medications known as immunomodulators. It is used […]


CNS infection
  by Yasser Metwally
I am professor Yasser Metwally, porofessor of neurology, Ain Shams university, Cairo, Egypt, Visit my web site at: www.yassermetwally.com This post contains simple medical information to neurological patients (vist […]


Agalsidase beta:
  by hijadoo
U.S. BRAND NAMES — Fabrazyme®PHARMACOLOGIC CATEGORY EnzymeDOSING: ADULTS — Fabry disease: I.V.: 1 mg/kg every 2 weeksDOSING: ELDERLY — Refer to adult dosing.DOSING: RENAL IMPAIRMENT — No dosage […]


Alglucosidase alfa
  by hijadoo
U.S. BRAND NAMES — Myozyme®PHARMACOLOGIC CATEGORY EnzymeDOSING: PEDIATRIC — Replacement therapy for Pompe disease (infantile onset): Children 1 month to 3.5 years (at first infusion): I.V.: 20 mg/kg […]


Traveling With Forteo
  by mcbones13
Today is my thirteenth day of injections and I’ve already had to learn how to travel with this medication. Forteo’s active ingredient is teriparatide, a man-made form of […]


Cerebral Infarction Therapy
  by stroketreatment
Cerebral infarction is not as dangerous as cerebral hemorrhage, but it should treat as soon as possible. As for most patients are in old age and weak, with several […]


Common treatments for stroke
  by stroketreatment
The stroke treatments are based on the different classifications of stroke. Generally speaking, stroke can be classified into to two types, including hemorrhagic stroke and ischemic stroke. Hemorrhagic stroke are divided into cerebral […]


Treatment Protocol for Osmotherapy of brain edema
  by Yasser Metwally
The author: Professor Yasser Metwally http://yassermetwally.com INTRODUCTION April 10, 2010 — Cerebral edema is frequently encountered in clinical practice in […]


Microbiology Lab Report
  by wwaini14
Staphlococcus Epidermidis/Subacute Bacterial Endocraditis Microbiology Lab Report In Microbiology Lab Section 3, Lab 3, unknown microorganism #2 was the one that I chose to identify, which […]


Glaucoma
  by miralac
Is a condition marked by high intraocular pressure (IOP) that damages the optic nerve. Two major forms: Acute Glaucoma Results when the angle between the iris and the cornea becomes […]



Other reviews about Mannitol Injection on web:

Learn about the prescription medication Mannitol IV (Mannitol Injection), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Mannitol IV (Mannitol Injection) Drug Information: Uses, Side ...


Mannitol injection To return to the main entry click here . What is mannitol injection? MANNITOL (Osmitrol®) is a diuretic Mannitol injection: Information from Answers.com


Accurate, FDA approved Mannitol Injection information for healthcare professionals and patients - brought to you by Drugs.com. Mannitol Injection Official FDA information, side effects and uses.


Mannitol I.V. (Mannitol Injection, USP) is indicated for the following purposes in adults and pediatric patients.Therapeutic Use: 1.Promotion of diuresis in the prevention or ... Mannitol Injection,Mannitol Infusion-China Manufacturer-Ningbo ...


All about Mannitol Injection 20%. View complete and up to date Mannitol Injection 20% veterinary information - part of the Drugs.com veterinary database. Mannitol Injection 20% Veterinary Information from Drugs.com


Learn about the prescription medication Osmitrol Injection in Viaflex (Mannitol Injection in Viaflex Plastic Container), drug uses, dosage, side effects, drug interactions ... Osmitrol Injection in Viaflex (Mannitol Injection in Viaflex ...


Aishwarya Healthcare - Exporter and supplier of IV fluids, metronidazole injection, mannitol injection, ciprofloxacin injection, ofloxacin injection, levofloxacin injection ... IV Fluids, Mannitol Injection, Ofloxacin Injection, Dextrose ...


Mannitol Injection, Find complete details about Mannitol,BP JP USP from Jiangsu Sihuan Bioengineering Co., Ltd.. You may also find other Mannitol,BP JP USP products or ... Mannitol Injection products, buy Mannitol Injection products from ...


Mannitol is for injection or infusion into a vein. It is given by a health-care professional in a hospital or clinic setting. What if I miss a dose? mannitol: Definition from Answers.com


Mannitol occurs naturally in fruits and vegetables. Mannitol Injection, USP is a sterile, nonpyrogenic, 25 percent solution of Mannitol in Water for Injection. DailyMed: About DailyMed





Featured Reviews

Reviews Dipentum

Dipentum Drug Description DIPENTUM® (olsalazine sodium) Capsules DRUG DESCRIPTION What are the possible side effects of olsalazine (Dipentum)? Get emergency medical help if you have any of these signs of an allergic reaction:...
Read More  |  Review This
Reviews Halog Cream

Halog Cream Drug Description HALOG® (halcinonide) Cream, USP 0.1% For Topical Use Only. Not For Ophthalmic Use. DRUG DESCRIPTION What are the possible side effects of halcinonide topical (Halog, Halog-E)? Get emergency...
Read More  |  Review This
Reviews Calcipotriene Ointment

Dovonex Ointment Drug Description Dovonex® (calcipotriene) Ointment, 0.005% FOR TOPICAL DERMATOLOGIC USE ONLY. Not for Ophthalmic, Oral or Intravaginal Use. DRUG DESCRIPTION What are the possible side effects of calcipotriene...
Read More  |  Review This
Reviews Erythromycin Ethylsuccinate

EryPed Drug Description Eryped 200 (erythromycin ethylsuccinate) Suspension Eryped 400 (erythromycin ethylsuccinate) Suspension Eryped Drops (erythromycin ethylsuccinate) Suspension To reduce the development of drug-resistant...
Read More  |  Review This
Reviews Metvixia

Metvixia Drug Description METVIXIA (methyl aminolevulinate) Cream, 16.8% For Topical Use Only DRUG DESCRIPTION What are the possible side effects of methyl aminolevulinate (Metvixia)? Get emergency medical help if you have any...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....